PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer

被引：0
|
作者：
Antonia, S. J. [1 ]
Villegas, A. [2 ]
Daniel, D. [3 ,4 ]
Baz, D. Vincente [5 ]
Murakami, S. [6 ]
Hui, R. [7 ,8 ]
Yokoi, T. [9 ]
Chiappori, A. [1 ]
Lee, K. H. [10 ]
de Wit, M. [11 ]
Cho, B. C. [12 ]
Bourhaba, M. [13 ]
Quantin, X. [14 ,15 ]
Tokito, T. [16 ]
Mekhail, T. [17 ]
Planchard, D. [18 ]
Jiang, H. [19 ]
Huang, Y. [19 ]
Dennis, P. A. [19 ]
Ozguroglu, M. [20 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Canc Specialists North Florida, Jacksonville, FL USA
[3] Tennessee Oncol, Chattanooga, TN USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[7] Westmead Hosp, Sydney, NSW, Australia
[8] Univ Sydney, Sydney, NSW, Australia
[9] Kansai Med Univ Hosp, Hirakata, Osaka, Japan
[10] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Cheongju, South Korea
[11] Vivantes Klinikum Neukoelln, Berlin, Germany
[12] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[13] Ctr Hosp Univ Liege, Liege, Belgium
[14] CHU Montpellier, Montpellier, France
[15] ICM Val dAurelle, Montpellier, France
[16] Kurume Univ Hosp, Kurume, Fukuoka, Japan
[17] Florida Hosp, Inst Canc, Orlando, FL USA
[18] Gustave Roussy, Villejuif, France
[19] AstraZeneca, Gaithersburg, MD USA
[20] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 05期
关键词：
D O I：
10.1016/j.ijrobp.2017.09.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA-4
引用
收藏
页码：1314 / 1315
页数：4
相关论文
共 50 条
  • [31] Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
    Gao, Robert W.
    Day, Courtney N.
    Yu, Nathan Y.
    Bush, Aaron
    Amundson, Adam C.
    Prodduturvar, Pranitha
    Majeed, Umair
    Butts, Emily
    Oliver, Thomas
    Schwecke, Anna J.
    Moffett, Jenesse N.
    Routman, David M.
    Breen, William G.
    Potter, Ashley L.
    Rivera-Concepcion, Joel
    Hoppe, Bradford S.
    Schild, Steven E.
    Sio, Terence T.
    Lou, Yanyan
    Ernani, Vinicius
    Ko, Stephen
    Olivier, Kenneth R.
    Merrell, Kenneth W.
    Garces, Yolanda, I
    Manochakian, Rami
    Harmsen, William S.
    Leventakos, Konstantinos
    Owen, Dawn
    LUNG CANCER, 2022, 170 : 58 - 64
  • [32] A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY OF MEDI4736 IN PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE 3 NSCLC WHO HAVE NOT PROGRESSED FOLLOWING PLATINUM-BASED, CONCURRENT CHEMORADIATION THERAPY (PACIFIC)
    Creelan, B.
    Iannotti, N. O.
    Salamat, M. A.
    Jayawardene, D.
    Ballas, M.
    Stockman, P. K.
    Antonia, S. J.
    ANNALS OF ONCOLOGY, 2015, 26
  • [33] COMPARATIVE EFFICACY OF CONSOLIDATION THERAPY AFTER CHEMORADIATION THERAPY (CRT) IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC): A NETWORK META-ANALYSIS
    Husain, F.
    Harari, O.
    Fazeli, M. S.
    Zhang, Y.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [34] Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria
    Sakaguchi, Tadashi
    Ito, Kentaro
    Furuhashi, Kazuki
    Nakamura, Yuki
    Suzuki, Yuta
    Nishii, Yoichi
    Taguchi, Osamu
    Hataji, Osamu
    RESPIRATORY INVESTIGATION, 2019, 57 (05) : 466 - 471
  • [35] A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA study
    Lu, Shun
    Chen, Gongyan
    Sun, Yuping
    Sun, Sanyuan
    Chang, Jianhua
    Yao, Yu
    Chen, Zhendong
    Ye, Feng
    Lu, Junguo
    Shi, Jianhua
    He, Jianxing
    Liu, Xiaoqing
    Zhang, Yiping
    Liu, Zhihua
    Fang, Jian
    Cheng, Ying
    Hu, Chunhong
    Mao, Weidong
    Hu, Yanping
    Gong, Youling
    Shan, Li
    Yang, Zhixiong
    Song, Yong
    Li, Wei
    Bai, Chong
    Wang, Buhai
    Ma, Rui
    Zheng, Zhendong
    Liu, Mingfang
    Jie, Zhijun
    Cao, Lejie
    Liao, Wangjun
    Pan, Hongming
    Huang, Dongning
    Chen, Yuan
    Yang, Jinji
    Qin, Shukui
    Ma, Shenglin
    Liang, Li
    Liu, Zhe
    Zhou, Jianying
    Tao, Min
    Huang, Yijiang
    Qiu, Feng
    Huang, Yunchao
    Guan, Sha
    Peng, Mengye
    Su, Weiguo
    LUNG CANCER, 2020, 146 : 252 - 262
  • [36] A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
    Prasad, Rahul N.
    Williams, Terence M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2040 - 2050
  • [37] Phase 3 study of pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy followed by durvalumab in unresectable, locally advanced, stage III non-small cell lung cancer: KEYLYNK-012.
    Jabbour, Salma K.
    Cho, Byoung Chul
    Bria, Emilio
    Kato, Terufumi
    Bhosle, Jaishree
    Gainor, Justin F.
    Reguart, Noemi
    Wang, Luhua
    Morgensztern, Daniel
    Gurary, Ellen
    Ashraf, Tanya B.
    Lara-Guerra, Humberto
    Reck, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB IN ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER AFTER CONCURRENT PLATINUM-BASED CHEMORADIATION IN FRANCE
    Tetafort, A.
    Haug, H.
    Le Pechoux, C.
    Chouaid, C.
    Gherardi, A.
    Caillon, M.
    Roze, S.
    Zang, A.
    VALUE IN HEALTH, 2019, 22 : S463 - S463
  • [39] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
    Han, Baohui
    Xiu, Qingyu
    Wang, Huimin
    Shen, Jie
    Gu, Aiqin
    Luo, Yi
    Bai, Chunxue
    Guo, Shuliang
    Liu, Wenchao
    Zhuang, Zhixiang
    Zhang, Yang
    Zhao, Yizhuo
    Jiang, Liyan
    Zhou, Jianying
    Jin, Xianqiao
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 1104 - 1109
  • [40] A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY OF MEDI4736 IN PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE NSCLC (STAGE III) WHO HAVE NOT PROGRESSED FOLLOWING PLATINUM-BASED, CONCURRENT CHEMORADIATION THERAPY (PACIFIC)
    Antonia, S.
    Iannotti, N. O.
    Salamat, M. A.
    Krebs, A. D.
    Jayawardene, D.
    Ballas, M.
    Stockman, P. K.
    ANNALS OF ONCOLOGY, 2014, 25
12345